ICB-induced vitiligo has been linked to a cross-reaction against antigens shared by normal melanocytes and melanoma cells, such as tyrosinase, MART-1, and GP100, as well as tyrosinase-related proteins 1 and 2 or tyrosinase. The gene discussed is TYR; the disease is melanoma.